Online personalities and individual social media users have for years hawked yerba mate and fiber products as methods to ...

Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials.

Some patients have reported 'a dulled response' to sources of pleasure beyond food ...

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella ...

A recent study tracked self-reported GLP-1 side effects among Reddit users and found several overlooked side effects like ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the treatment of type 2 diabetes and obesity. However, for many users, the benefits of weight loss and blood sugar management come ...

If you’re looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) receptor ...

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or experience more nausea and vomiting on GLP-1 drugs. The findings suggest ...

The most well-known use of GLP-1 receptor agonist drugs (aside from their original intended use for blood sugar control) is weight management. But emerging research suggests the medications offer ...

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...

Combining GLP-1 agonists with progestins lowered endometrial cancer risk by 66% compared to progestins alone. The GLP-1 agonist/progestin combination outperformed metformin/progestins in reducing ...

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer. HealthDay News — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) seem ...